Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

BACKGROUND: Critically ill coronavirus disease 2019 (COVID-19) patients have a high risk of acute kidney injury (AKI) that requires renal replacement therapy (RRT). A state of hypercoagulability reduces circuit life spans. To maintain circuit patency and therapeutic efficiency, an optimized anticoag...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Frederic, Westermann, Lukas, Rieg, Siegbert, Neumann-Haefelin, Elke, Biever, Paul Marc, Walz, Gerd, Kalbhenn, Johannes, Tanriver, Yakup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668013/
https://www.ncbi.nlm.nih.gov/pubmed/33198670
http://dx.doi.org/10.1186/s12882-020-02150-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668013/
https://www.ncbi.nlm.nih.gov/pubmed/33198670
http://dx.doi.org/10.1186/s12882-020-02150-8

Ejemplares similares